MS  >> Vol. 10 No. 2 (February 2020)

    Progress of Nanomaterials Regulating Tumor-Associated Macrophages for Tumor Immunotherapy

  • 全文下载: PDF(1681KB) HTML    PP.75-83   DOI: 10.12677/MS.2020.102010  
  • 下载量: 102  浏览量: 194   科研立项经费支持


徐 睿,刘晨光:中国海洋大学,山东 青岛

肿瘤相关巨噬细胞纳米材料表型极化Tumor-Associated Macrophage Nano-Drug Carrier Phenotypic Polarization


骨髓源巨噬细胞和组织常驻巨噬细胞,统称为肿瘤相关巨噬细胞(Tumor-Associated Macrophages, TAMs),存在于肿瘤微环境中,在肿瘤治疗方面备受关注。本文在阐明TAMs促肿瘤生长机制的基础上,总结了靶向TAMs的作用机制和治疗策略,重点介绍了纳米药物载体如何通过靶向调控TAMs进行肿瘤的免疫治疗。纳米药物载体主要通过阻断TAMs的存活或影响其信号级联、限制TAMs向肿瘤的募集以及逆转促肿瘤的M2型TAMs至抗肿瘤的M1型发挥抗肿瘤作用。以上内容显示纳米材料由于其特殊的物化性质,能够靶向TAMs,并通过多种途径调控TAMs,增强抗肿瘤免疫反应,具有非常好的免疫治疗的发展前景。

Macrophages derived from bone marrow and tissue resident macrophages, collectively referred to as tumor associated macrophages (TAMs), are present in the tumor microenvironment and have attracted considerable attention in the treatment of tumors. Based on the clarification of the mechanism of TAMs to promote tumor growth, this article summarizes the mechanism of action and treatment strategies of targeted TAMs and focuses on how nanomedicine carriers can target tumor immunotherapy through targeted TAMs regulation. Nanodrug carriers have an antitumor effect mainly by preventing the survival of TAMs or disrupting their signal cascades, reducing the recruitment of TAMs to tumors, and reversing the tumor promoting M2 type TAMs to the antitumor type M1. The above content shows that, due to their different physical and chemical properties, nanomaterials can target TAMs and regulate TAMs in a number of ways to enhance the antitumor immune response, which has very good prospects for growth in immunotherapy.

徐睿, 刘晨光. 纳米材料调控肿瘤相关巨噬细胞进行肿瘤免疫治疗的研究进展[J]. 材料科学, 2020, 10(2): 75-83.


[1] Kerkar, S.P. and Restifo, N.P. (2012) Cellular Constituents of Immune Escape within the Tumor Microenvironment. Cancer Research, 72, 3125-3130.
[2] Mantovani, A., Marchesi, F., Malesci, A., Laghi, L. and Allavena, P. (2017) Tumor-Associated Macrophages as Treatment Targets in Oncology. Nature Reviews Clinical Oncology, 14, 399-416.
[3] Cannarile, M. A., Ries, C. H., Hoves, S., & Rüttinger, D. (2014) Targeting Tumor-Associated Macrophages in Cancer Therapy and Understanding Their Complexity. Oncoimmunology, 3, Article ID: e955356.
[4] Zhou, X. and Li, G. (2013) Function of Tumor-Associated Macrophages in Gastric Cancer. Chinese Journal of Clinical Oncology, No. 20, 1261-1263.
[5] Grivennikov, S.I., Greten, F.R. and Karin, M. (2010) Immunity, Inflammation, and Cancer. Cell, 140, 883-899.
[6] Martinez, F.O. and Gordon, S. (2014) The M1 and M2 Paradigm of Macrophage Activation: Time for Reassessment. F1000Prime Reports, 6, 13.
[7] Ferrante, C.J. and Leibovich, S.J. (2012) Regulation of Macrophage Polarization and Wound Healing. Advances in Wound Care, 1, 10-16.
[8] Murray, P.J., Allen, J.E., Biswas, S.K, Fisher, E.A, Gilroy, D.W., Goerdt, S., et al. (2014) Macrophage Activation and Polarization: Nomenclature and Experimental Guidelines. Immunity, 41, 14-20.
[9] Allavena, P. and Mantovani, A. (2012) Immunology in the Clinic Review Series; Focus on Cancer: Tumor-Associated Macrophages: Undisputed Stars of the Inflammatory Tumor Microenvironment. Clinical & Experimental Immunology, 167, 195-205.
[10] Qian, B.Z. and Pollard, J.W. (2010) Macrophage Diversity Enhances Tumor Progression and Metastasis. Cell, 141, 39-51.
[11] Yang, L. and Zhang, Y. (2017) Tumor-Associated Macrophages: From Basic Research to Clinical Application. Journal of Hematology & Oncology, 10, 58.
[12] Herwig, M.C., Bergstrom, C., Wells, J.R., Höller, T. and Grossniklaus, H.E. (2013) M2/M1 Ratio of Tumor Associated Macrophages and PPAR-Gamma Expression in Uveal Melanomas with Class 1 and Class 2 Molecular Profiles. Experimental Eye Research, 107, 52-58.
[13] Granata, F., Frattini, A., Loffredo, S., et al. (2010) Production of Vascular Endothelial Growth Factors from Human Lung Macrophages Induced by Group IIA and Group X Secreted Phospholipases A2. The Journal of Immunology, 184, 5232-5241.
[14] Lala, P.K., Pinki, N. and Mousumi, M. (2018) Roles of Prostaglandins in Tumor-Associated Lymph Angiogenesis with Special Reference to Breast Cancer. Cancer and Metastasis Reviews, 37, 369-384.
[15] Qian, B., Li, J., Zhang, H., et al. (2011) CCL2 Recruits Inflammatory Monocytes to Facilitate Breast-Tumor Metastasis. Nature, 475, 222-225.
[16] Gocheva, V., Wang, H.W., Gadea, B.B., et al. (2010) IL-4 Induces Cathepsin Protease Activity in Tumor-Associated Macrophages to Promote Cancer Growth and Invasion. Genes & Development, 24, 241-255.
[17] Germano, G., Frapolli, R., Belgiovine, C., et al. (2013) Role of Macrophage Targeting in the Antitumor Activity of Trabectedin. Cancer Cell, 23, 249-262.
[18] Gratchev, A., Kzhyshkowska, J., Kirsten, K., et al. (2006) Mφ1 and Mφ2 Can Be Re-Polarized by Th2 or Th1 Cytokines, Respectively, and Respond to Exogenous Danger Signals. Immunobiology, 211, 473-486.
[19] Gordon, S. and Martinez, F.O. (2010) Alternative Activation of Macrophages: Mechanism and Functions. Immunity, 32, 593-604.
[20] Huang, Z., Yang, Y., Jiang, Y., et al. (2013) Anti-Tumor Immune Responses of Tumor-Associated Macrophages via Toll-Like Receptor 4 Triggered by Cationic Polymers. Biomaterials, 34, 746-755.
[21] Chang, Y.-N., Guo, H.L., Li, J., et al. (2013) Adjusting the Balance between Effective Loading and Vector Migration of Macrophage Vehicles to Deliver Nanoparticles. PLoS ONE, 8, e76024.
[22] Jiang, W., Kim, B.Y.S., Rutka, J.T. and Chan, W.C.W. (2008) Nanoparticle-Mediated Cellular Response Is Size-Dependent. Nature Nanotechnology, 3, 145-150.
[23] Cai, X.J., Wang, Z., Cao, J.W., Ni, J.J., Xu, Y.Y., Yao, J. and Yang, G.Y. (2017) Anti-Angiogenic and Anti-Tumor Effects of Metronomic Use of Novel Liposomal Zoledronic Acid Depletes Tumor-Associated Macrophages in Triple Negative Breast Cancer. Oncotarget, 8, 84248-84257.
[24] Ye, J., Yang, Y., Dong, W., et al. (2019) Drug-Free Mannosylated Liposomes Inhibit Tumor Growth by Promoting the Polarization of Tumor-Associated Macrophages. International Journal of Nanomedicine, 14, 3203-3220.
[25] Han, S., Wang, W., Wang, S., et al. (2019) Multifunctional Biomimetic Nanoparticles Loading Baicalin for Polarizing Tumor-Associated Macrophages. Nanoscale, 11, 20206-20220.
[26] Zanganeh, S., Hutter, G., Spitler, R., Lenkov, O., Mahmoudi, M., Shaw, A. and Daldrup-Link, H.E. (2016). Iron Oxide Nanoparticles Inhibit Tumour Growth by inducing Pro-Inflammatory Macrophage Polarization in Tumor Tissues. Nature Nanotechnology, 11, 986-994.
[27] Chen, L., Ma, X., Dang, M., et al. (2019) Cancer Immunotherapy: Simultaneous T Cell Activation and Macrophage Polarization to Promote Potent Tumor Suppression by Iron Oxide-Embedded Large-Pore Mesoporous Organosilica Core-Shell Nanospheres. Advanced Healthcare Materials, 8, Article ID: 1900039.
[28] Wu, L., Tang, H., Zheng, H., et al. (2019) Multiwalled Carbon Nanotubes Prevent Tumor Metastasis Through Switching M2-Polarized Macrophages to M1 via TLR4 Activation. Journal of Biomedical Nanotechnology, 15, 138-150.
[29] Ma, J., Liu, R., Wang, X., et al. (2015) A Crucial Role of Lateral Size for Graphene Oxide in Activating Macrophages and Stimulating Pro-Inflammatory Responses in Cells and Animals. ACS Nano, 9, 10498-10515.
[30] Wang, L., Wang, M., Zhou, B., et al. (2019) PEGylated Reduced-Graphene Oxide Hybridized with Fe3O4 Nanoparticles for Cancer Photothermal-Immunotherapy. Journal of Materials Chemistry B, 7, 7406-7414.